Company to host conference call and webcast on Tuesday, April 2 at 8:30am EDT LYON , France, March 21, 2019  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the fourth quarter and year ended December 31,

Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence LYON, France - April 1, 2019 - EDAP TMS SA (Nasdaq: EDAP) , the global leader in therapeutic ultrasound, today announced that

Reports record revenues for the fifth consecutive year Record fiscal year 2018 revenues of €39.2 million Q4 2018 HIFU net sales increased 79% year-over-year Profitable and cash flow positive during the fourth quarter of 2018 Completed first U.S. sale of Focal One at the end of 2018 Ended the year

EDAP to Provide Live Demonstrations and Host Q&A with Interested Parties at Booth #2211 LYON , France, April 29, 2019 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it will demonstrate the capabilities of its range of minimally-invasive therapeutic

Company to host conference call and webcast on Thursday, May 16 , at 8:30 am EDT LYON, France , May 2, 2019  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2019 after the

EDAP Reports 2019 First Quarter Results HIFU revenue growth of 58.6% year-over-year Profitable for second consecutive quarter Total Q1 revenues of EUR 10.1 million ; strongest Q1 to date Improved Q1 gross profit margin by 4.2 percentage points vs prior year LYON, France , May 15, 2019 -- EDAP TMS

AMA allocates a new Category 1 CPT code for High Intensity Focused Ultrasound (HIFU)   Definitive CPT code will cover the transrectal ablation of malignant prostate tissue with HIFU including ultrasound guidance LYON, France , June 10, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”) , the global

45% growth in total Q2 2019 revenue year-over-year   78% growth in HIFU sales year-to-date through June 30, 2019   Company to Report Second Quarter 2019 Financial Results on Wednesday, August 28, 2019 and to host conference call and webcast on Thursday August 29 , at 8:30 am EDT LYON, France , July

Third consecutive profitable quarter Positive reimbursement decision by the American Medical Association announced in June Significant improvement in gross profit margin from 41.3% in Q2 2018 to 50.7% in Q2 2019 Q2 HIFU sales growth of 98% year-over-year Total Q2 revenues of EUR 12.5 million ; +45%

Company to host conference call and webcast on Thursday, November 14 , at 8:30 am EDT LYON, France , October 24, 2019  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended